Copyright Reports & Markets. All rights reserved.

Global and Japan Postoperative Nausea and Vomiting (PONV) Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Serotonin Antagonists
    • 1.2.3 Steroids
    • 1.2.4 Dopamine Antagonists
    • 1.2.5 NK-1 Receptor Antagonists
    • 1.2.6 Others
    • 1.2.7 Non-pharmacologic Treatment
  • 1.3 Market by Application
    • 1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Online Pharmacies
    • 1.3.4 Retail Pharmacies and Drug Stores
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Postoperative Nausea and Vomiting (PONV) Market Perspective (2015-2026)
  • 2.2 Global Postoperative Nausea and Vomiting (PONV) Growth Trends by Regions
    • 2.2.1 Postoperative Nausea and Vomiting (PONV) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Postoperative Nausea and Vomiting (PONV) Historic Market Share by Regions (2015-2020)
    • 2.2.3 Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Market Size
    • 3.1.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue (2015-2020)
    • 3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2015-2020)
  • 3.2 Global Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Postoperative Nausea and Vomiting (PONV) Revenue
  • 3.4 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio
    • 3.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting (PONV) Revenue in 2019
  • 3.5 Key Players Postoperative Nausea and Vomiting (PONV) Area Served
  • 3.6 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
  • 3.7 Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Type (2015-2026)

  • 4.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2015-2020)
  • 4.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2021-2026)

5 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Application (2015-2026)

  • 5.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Application (2015-2020)
  • 5.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2015-2026)
  • 6.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020)
  • 6.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020)
  • 6.4 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2015-2026)
  • 7.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020)
  • 7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020)
  • 7.4 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Postoperative Nausea and Vomiting (PONV) Market Size (2015-2026)
  • 8.2 China Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020)
  • 8.3 China Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020)
  • 8.4 China Postoperative Nausea and Vomiting (PONV) Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Postoperative Nausea and Vomiting (PONV) Market Size (2015-2026)
  • 9.2 Japan Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020)
  • 9.3 Japan Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020)
  • 9.4 Japan Postoperative Nausea and Vomiting (PONV) Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size (2015-2026)
  • 10.2 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Acacia Pharma
    • 11.1.1 Acacia Pharma Company Details
    • 11.1.2 Acacia Pharma Business Overview
    • 11.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Introduction
    • 11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020))
    • 11.1.5 Acacia Pharma Recent Development
  • 11.2 F. Hoffmann-La Roche
    • 11.2.1 F. Hoffmann-La Roche Company Details
    • 11.2.2 F. Hoffmann-La Roche Business Overview
    • 11.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Introduction
    • 11.2.4 F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
    • 11.2.5 F. Hoffmann-La Roche Recent Development
  • 11.3 Novartis
    • 11.3.1 Novartis Company Details
    • 11.3.2 Novartis Business Overview
    • 11.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Introduction
    • 11.3.4 Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
    • 11.3.5 Novartis Recent Development
  • 11.4 Ani Pharmaceuticals
    • 11.4.1 Ani Pharmaceuticals Company Details
    • 11.4.2 Ani Pharmaceuticals Business Overview
    • 11.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Introduction
    • 11.4.4 Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
    • 11.4.5 Ani Pharmaceuticals Recent Development
  • 11.5 Camurus
    • 11.5.1 Camurus Company Details
    • 11.5.2 Camurus Business Overview
    • 11.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Introduction
    • 11.5.4 Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
    • 11.5.5 Camurus Recent Development
  • 11.6 Sanofi
    • 11.6.1 Sanofi Company Details
    • 11.6.2 Sanofi Business Overview
    • 11.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Introduction
    • 11.6.4 Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
    • 11.6.5 Sanofi Recent Development
  • 11.7 Helsinn Holding
    • 11.7.1 Helsinn Holding Company Details
    • 11.7.2 Helsinn Holding Business Overview
    • 11.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Introduction
    • 11.7.4 Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
    • 11.7.5 Helsinn Holding Recent Development
  • 11.8 Eisai
    • 11.8.1 Eisai Company Details
    • 11.8.2 Eisai Business Overview
    • 11.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Introduction
    • 11.8.4 Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
    • 11.8.5 Eisai Recent Development
  • 11.9 Merck
    • 11.9.1 Merck Company Details
    • 11.9.2 Merck Business Overview
    • 11.9.3 Merck Postoperative Nausea and Vomiting (PONV) Introduction
    • 11.9.4 Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
    • 11.9.5 Merck Recent Development
  • 11.10 GlaxoSmithKline
    • 11.10.1 GlaxoSmithKline Company Details
    • 11.10.2 GlaxoSmithKline Business Overview
    • 11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Introduction
    • 11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2015-2020)
    • 11.10.5 GlaxoSmithKline Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Postoperative Nausea and Vomiting (PONV) Scope and Market Size
    Postoperative Nausea and Vomiting (PONV) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Postoperative Nausea and Vomiting (PONV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Serotonin Antagonists
    Steroids
    Dopamine Antagonists
    NK-1 Receptor Antagonists
    Others
    Non-pharmacologic Treatment

    Market segment by Application, split into
    Hospital Pharmacies
    Online Pharmacies
    Retail Pharmacies and Drug Stores

    Based on regional and country-level analysis, the Postoperative Nausea and Vomiting (PONV) market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Postoperative Nausea and Vomiting (PONV) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Acacia Pharma
    F. Hoffmann-La Roche
    Novartis
    Ani Pharmaceuticals
    Camurus
    Sanofi
    Helsinn Holding
    Eisai
    Merck
    GlaxoSmithKline

    Buy now